ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.25
-0.40 (-7.08%)
May 19, 2026, 4:00 PM EDT - Market closed
ImageneBio Employees
ImageneBio had 15 employees as of December 31, 2025. The number of employees increased by 5 or 50.00% compared to the previous year.
Employees
15
Change
5
Growth
50.00%
Revenue / Employee
n/a
Profits / Employee
-$3,592,400
Market Cap
59.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 5 | 50.00% |
| Mar 31, 2025 | 9 | - | - |
| Dec 31, 2024 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 142 |
| MindWalk Holdings | 102 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Entera Bio | 22 |
| Actuate Therapeutics | 12 |
| Dogwood Therapeutics | 8 |
| MediciNova | 6 |
IMA News
- 11 days ago - ImageneBio price target lowered to $24 from $30 at Leerink - TheFly
- 12 days ago - ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update - GlobeNewsWire
- 12 days ago - ImageneBio Quarterly report: Q1 2026 - Filings
- 12 days ago - ImageneBio Earnings release: Q1 2026 - Filings
- 19 days ago - ImageneBio Proxy statement: Proxy filing - Filings
- 19 days ago - ImageneBio Proxy statement: Proxy filing - Filings
- 5 weeks ago - ImageneBio Announces $30 Million Private Placement - GlobeNewsWire
- 2 months ago - ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire